SCHEMBL7022340

SCHEMBL7022340

CC(=O)CCC(c1ncc[nH]1)S(=O)(=O)N1CCC(Oc2ccc(Cl)cn2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.48
FPR2 P25090 1/20 0.45
PROKR1 Q8TCW9 1/20 0.45
TDO2 P48775 1/20 0.37
F10 P00742 1/20 0.36
LIPE Q05469 1/20 0.35
DGAT1 O75907 3/20 0.35
SOAT1 P35610 3/20 0.35
KCNH2 Q12809 3/20 0.35
IP6K1 Q92551 1/20 0.34
CACNB4 O00305 2/20 0.33
CACNA1A O00555 2/20 0.33
CACNA1G O43497 2/20 0.33
CACNG3 O60359 2/20 0.33
CACNA1F O60840 2/20 0.33
CACNA1H O95180 2/20 0.33
CACNB3 P54284 2/20 0.33
CACNA2D1 P54289 2/20 0.33
CACNG7 P62955 2/20 0.33
CACNA1B Q00975 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014611 0.86 MMP1 (0.51) MMP1FPR2PROKR1TDO2LIPE
SCHEMBL7021130 0.79 MMP1 (0.52) MMP1FPR2PROKR1TDO2LIPE
SCHEMBL7018357 0.78 MMP1 (0.49) MMP1FPR2PROKR1TDO2LIPE
SCHEMBL7011537 0.77 MMP1 (0.52) MMP1FPR2PROKR1TDO2LIPE
SCHEMBL7018853 0.77 MMP1 (0.56) MMP1FPR2PROKR1TDO2LIPE
SCHEMBL7018466 0.75 MMP1 (0.54) MMP1FPR2PROKR1TDO2LIPE
SCHEMBL940600 0.75 MMP1 (0.57) MMP1FPR2PROKR1TDO2LIPE
SCHEMBL6021557 0.73 MMP1 (0.52) MMP1FPR2PROKR1TDO2LIPE
SCHEMBL7023218 0.72 MMP1 (0.53) MMP1FPR2PROKR1TDO2LIPE
SCHEMBL7023309 0.72 MMP1 (0.57) MMP1FPR2PROKR1TDO2LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370536-A1 METALLOPROTEINASE INHIBITORS AstraZeneca AB (SE) 2003-12-17 EP disclosed
EP-1370556-A1 METALLOPROTEINASE INHIBITORS AstraZeneca AB (SE) 2003-12-17 EP disclosed
WO-2002074767-A1 METALLOPROTEINASE INHIBITORS ASTRAZENECA AB (SE) 2002-09-26 WO disclosed
WO-2002074750-A1 METALLOPROTEINASE INHIBITORS ASTRAZENECA AB (SE) 2002-09-26 WO disclosed